<DOC>
	<DOCNO>NCT02440945</DOCNO>
	<brief_summary>It interventional study.The use blot paper call `` Dried Blood Spot '' DBS method systematic neonatal screen metabolic disease . Indeed , multiple interest : realize thanks lancet , much less invasive classic blood collection . Besides , transport blood sample facilitated analyst stable DBS room temperature one week . Finally use DM reduce infectious risk bound manipulation blood sample inactivation microorganism . The moderate result vitamin D , albumin , prealbumin , CRP , orosomucoide The DBS present major interest care old fragile people one hand low peripheral venous capital hand possibility dosage DBS allow facilitate biological follow-up . Indeed important detect soon possible fragile old people , big risk see health degrade physical , psychic social stress , concentrate effort coverage limit risk . The advantage biological criterion speed test making ( blood test ) , absence necessity active participation patient ( clinical criterion require test patient walking , test muscular strength , etc . ) save time diagnosis clinician . The blood biological marker fragility essentially rate 25OH vitamin D , marker undernutrition ( albumin , prealbumin ) inflammation ( CRP , orosomucoïde ) . These last four parameter measurable DBS thanks quantitative mass spectrometry .</brief_summary>
	<brief_title>Use DBS Follow-up Blood Clinical Parameters Old People</brief_title>
	<detailed_description>Main objective : Define analytical concordance dosage realize blot paper ( DBS ) classic dosage blood test five marker . Secondary objective : Study influence hématocrite , hemoglobin , total protein dosage DBS , realize biological collection blood sample DBS . Methods Feasibility : The recruitment patient make Service Geriatrics CHRU Montpellier ( Pr C. Jeandel , Dr G. Baptista ) , important number compatible patient number plan patient study . In standard blood result add capillary take deposit 3 DBS . The study concordance biological method include one hand analytical evaluation new method term reproducibility , repeatability , limit detection quantification . On hand , comparison value dosages venous take ( blood test ) normal pathological value realize method Bland Altman associate regression balance Deming . Calendar study : M0-M6 : optimization analytical method / M0-M3 : Statutory clinical part ( CPP.. ) M4-M16 : inclusion patient / M6-M20 : validation dosages DBS M12-M24 : valuation result ( scientific article , presentation , exploit know-how ) Perspectives : To able realize thanks DBS follow-up biological parameter old people major step forward patient avoid classic blood test facilitate preanalytical phase , make easily compatible telemedicine particular , dosages practicable home , retirement home , doctor 's office , simple postal send analysis laboratory .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>inclusion criterion : Man / woman Having standard blood test plan consultation hospitalization service Geriatrics Pr C. Jeandel Signature inform consent patient Patient affiliate national health insurance exclusion criterion : Absence sign informed consent Patients cutaneous disorder increase risk cause blood test ( cutaneous infection )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>